We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
+$14.9M
Cap. Flow %
4.04%
Top 10 Hldgs %
6.4%
Holding
553
New
113
Increased
199
Reduced
149
Closed
92

Top Buys

Rank Stock Value
1
EXPD icon
Expeditors International
EXPD
+$2.17M
2
INCY icon
Incyte
INCY
+$2.09M
3
WAT icon
Waters Corp
WAT
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.5M
2
EA
Electronic Arts
EA
+$2.43M
3
FOXA icon
Fox Class A
FOXA
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
151
Travere Therapeutics
TVTX
$5.78B
$750K 0.2%
19,620
-10,125
-34% -$329K
HALO icon
152
Halozyme
HALO
$12.2B
$739K 0.2%
10,984
+2,836
+35% +$191K
PFLT icon
153
PennantPark Floating Rate Capital
PFLT
$746M
$739K 0.2%
79,701
-13,142
-14% -$119K
PNNT
154
Pennant Park Investment Corp
PNNT
$241M
$734K 0.2%
123,166
-15,952
-11% -$99.7K
EXEL icon
155
Exelixis
EXEL
$13.4B
$733K 0.2%
16,716
+6,079
+57% +$251K
NUVB icon
156
Nuvation Bio
NUVB
$2.32B
$726K 0.2%
81,068
+18,202
+29% +$113K
CSWC icon
157
Capital Southwest
CSWC
$1.6B
$724K 0.2%
32,682
-7,479
-19% -$158K
CION icon
158
CION Investment
CION
$374M
$720K 0.2%
74,429
-22,157
-23% -$214K
BTX
159
BlackRock Technology and Private Equity Term Trust
BTX
$1B
$718K 0.2%
108,899
-25,608
-19% -$172K
REGN icon
160
Regeneron Pharmaceuticals
REGN
$80.8B
$711K 0.19%
921
+69
+8% +$46.9K
SNDX icon
161
Syndax Pharmaceuticals
SNDX
$1.82B
$705K 0.19%
33,549
+22,885
+215% +$399K
BCRX icon
162
BioCryst Pharmaceuticals
BCRX
$2.4B
$704K 0.19%
90,278
+47,548
+111% +$344K
AMGN icon
163
Amgen
AMGN
$222B
$704K 0.19%
2,150
+655
+44% +$208K
TBPH icon
164
Theravance Biopharma
TBPH
$877M
$704K 0.19%
37,611
-4,273
-10% -$70.9K
NVAX icon
165
Novavax
NVAX
$1.31B
$699K 0.19%
104,019
+41,866
+67% +$316K
GILD icon
166
Gilead Sciences
GILD
$165B
$697K 0.19%
5,675
+1,709
+43% +$208K
BBIO icon
167
BridgeBio Pharma
BBIO
$16.5B
$696K 0.19%
9,093
-2,115
-19% -$139K
MDGL icon
168
Madrigal Pharmaceuticals
MDGL
$11.8B
$695K 0.19%
1,194
-301
-20% -$154K
KURA icon
169
Kura Oncology
KURA
$850M
$695K 0.19%
66,870
+49,785
+291% +$522K
GAIN icon
170
Gladstone Investment Corp
GAIN
$661M
$691K 0.19%
49,495
-20,759
-30% -$288K
BIIB icon
171
Biogen
BIIB
$30.7B
$690K 0.19%
3,923
+564
+17% +$92.1K
MFIC icon
172
MidCap Financial Investment
MFIC
$804M
$689K 0.19%
60,236
-9,997
-14% -$119K
KRYS icon
173
Krystal Biotech
KRYS
$9.66B
$688K 0.19%
2,792
-375
-12% -$78.9K
AUPH icon
174
Aurinia Pharmaceuticals
AUPH
$2.11B
$688K 0.19%
43,117
-10,880
-20% -$154K
TARS icon
175
Tarsus Pharmaceuticals
TARS
$2.84B
$688K 0.19%
8,399
-2,453
-23% -$183K
5 6
7
8 9

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Virtus Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Virtus Investment Advisers held 553 positions worth $368M, up 5.3% from $349M the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Virtus Investment Advisers deployed $14.9M of net new capital in Q4 2025, opening 113 new positions and adding to 199 existing holdings. Its largest new stake was Expeditors International: 15,974 shares worth $2.38M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was VICI Properties, an estimated $1.66M trimmed.

  • Virtus Investment Advisers's largest Q4 2025 buy was Expeditors International: 15,974 shares worth $2.38M.
  • Virtus Investment Advisers added most to Incyte in Q4 2025, an estimated $2.09M increase.
  • Virtus Investment Advisers's biggest Q4 2025 reduction was VICI Properties, cutting an estimated $1.66M.
  • Virtus Investment Advisers fully exited Tesla in Q4 2025, selling an estimated $2.5M.
  • Virtus Investment Advisers's ten largest holdings make up 6.4% of its $368M portfolio in Q4 2025.
  • Virtus Investment Advisers opened 113 new positions and closed 92 in Q4 2025.
  • Virtus Investment Advisers's portfolio value rose 5.3% quarter-over-quarter to $368M.

Based on Virtus Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.